Singapore, Aug. 28 -- AUScelerate and the Shanghai Center of Biomedicine Development have signed a Memorandum of Understanding (MoU) to build collaborative links and open-up new market opportunities for Australian life science companies.

The MoU was signed in Melbourne by AUScelerate CEO and Managing Director Stuart Dignam and Zhang Hua, Deputy Director of the Shanghai Center of Biomedicine Development.

The agreement, witnessed by the Chairman of the Shanghai Municipal Commission of Science and Technology, Dr Luo Dajin, establishes a three-year collaboration framework.

AUScelerate's Stuart Dignam says the partnership aims to make a material difference in the way Australian life science innovators engage with Shanghai's innovation ecosy...